SCH[removed]DIPROSONE CREAM SECTION 2 DRAFT LABELING

First Page		Document Content
Date: 2003-10-16 17:52:11 Pharmacology Organofluorides Health Anxiety Stress Corticosteroid Topical steroid Betamethasone Hypothalamic–pituitary–adrenal axis Glucocorticoids Medicine Otologicals		SCH[removed]DIPROSONE CREAM SECTION 2 DRAFT LABELING Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 33,45 KB Share Document on Facebook

	PRODUCT MONOGRAPH DIPROLENE® Glycol OINTMENT/CREAM/LOTION (betamethasone dipropionate 0.05% W/W) DocID: 1v6ee - View Document
	PRESCRIBING INFORMATION CELESTONE® SOLUSPAN® (Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP) DocID: 1uiZO - View Document
	PRODUCT MONOGRAPH DIPROSONE® Betamethasone Dipropionate Cream, Merck Standard, 0.05% W/W betamethasone (as dipropionate) Betamethasone Dipropionate Ointment, Merck Standard, DocID: 1tRhH - View Document
	RQ105300 BETAVET® (Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension) DocID: 1sKaA - View Document
	BetaVet® Safety Data Sheet According To Federal Register / Vol. 77, NoMonday, March 26, Rules And Regulations Revision Date: Date of issue: DocID: 1qlPS - View Document